Patents by Inventor Scott J. Bultman

Scott J. Bultman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Agouti polynucleotide compositions and methods of use
    Patent number: 6514747
    Abstract: Disclosed are methods and compositions comprising novel agouti polypeptides and the polynucleotides which encode them. Also disclosed are DNA segments encoding these proteins derived from human and murine cell lines, and the use of these polynucleotides and polypeptides in a variety of diagnostic and therapeutic applications. Methods, compositions, kits, and devices are also provided for identifying compounds which are inhibitors of agouti activity, and for altering fatty acid synthetase activity and intracellular calcium levels in transformed cells.
    Type: Grant
    Filed: February 12, 2001
    Date of Patent: February 4, 2003
    Assignee: UT-Battelle, LLC
    Inventors: Richard P. Woychik, Scott J. Bultman, Edward J. Michaud
  • Agouti polynucleotide compositions and methods of use
    Publication number: 20020151463
    Abstract: Disclosed are methods and compositions comprising novel agouti polypeptides and the polynucleotides which encode them. Also disclosed are DNA segments encoding these proteins derived from human and murine cell lines, and the use of these polynucleotides and polypeptides in a variety of diagnostic and therapeutic applications. Methods, compositions, kits, and devices are also provided for identifying compounds which are inhibitors of agouti activity, and for altering fatty acid synthetase activity and intracellular calcium levels in transformed cells.
    Type: Application
    Filed: February 12, 2001
    Publication date: October 17, 2002
    Inventors: Richard P. Woychik, Scott J. Bultman, Edward J. Michaud
  • Agouti polypeptide compositions
    Patent number: 6310034
    Abstract: Disclosed are methods and compositions comprising novel agouti polypeptides and the polynucleotides which encode them. Also disclosed are DNA segments encoding these proteins derived from human and murine cell lines, and the use of these polynucleotides and polypeptides in a variety of diagnostic and therapeutic applications. Methods, compositions, kits, and devices are also provided for identifying compounds which are inhibitors of agouti activity, and for altering fatty acid synthetase activity and intracellular calcium levels in transformed cells.
    Type: Grant
    Filed: March 3, 1998
    Date of Patent: October 30, 2001
    Assignee: UT-Battelle, LLC
    Inventors: Richard P. Woychik, Scott J. Bultman, Edward J. Michaud